PBH(Prestige Consumer Healthcare Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2022-03-31 | FY 截至 2023-03-31 | FY 截至 2024-03-31 | FY 截至 2025-03-31 | FY 截至 2026-03-31 |
|---|---|---|---|---|---|
| 营业收入 | $1.09B | $1.13B | $1.13B | $1.14B | $1.09B |
| 毛利润 | $620.65M | $625.29M | $624.45M | $634.46M | $595.58M |
| 营业利润 | $329.92M | −$22.41M | $342.43M | $336.77M | $309.41M |
| 净利润 | $205.38M | −$82.31M | $209.34M | $214.60M | $190.30M |
| 经营现金流 | $259.92M | $229.72M | $248.93M | $251.51M | $257.63M |
| 自由现金流 | $250.28M | $221.93M | $239.38M | $243.29M | $246.45M |
| 摊薄每股收益 | $4.04 | $-1.65 | $4.17 | $4.29 | $3.91 |